Topic Review
Atherosclerotic Cardiovascular Diseases
Atherosclerotic cardiovascular diseases (ASCVD) are the major cause of mortality worldwide. Despite the continuous progress in ASCVD therapy, the residual risk persists beyond the management of traditional risk factors. Several infections including Helicobacter pylori infection, periodontal disease, and viral infections are associated with the increased risk of ASCVD, both directly by damage to the heart muscle and vasculature, and indirectly by triggering a systemic proinflammatory state. Hence, beyond the optimal management of the traditional ASCVD risk factors, infections should be considered as an important non-classical risk factor to enable early diagnosis and appropriate treatment. 
  • 881
  • 29 Jan 2022
Topic Review
Atherothrombosis in Progression of Non-Coronary Artery Disease
Peripheral artery disease (PAD) encompasses a variety of non-coronary artery diseases, and its prevalence varies based on screening approaches and clinical features. Recent data reveal a global prevalence of 80 million strokes, the majority (87%) of which are ischemic.
  • 365
  • 25 Apr 2023
Topic Review
Athletes and COVID-19
The COVID-19 pandemic is having major economic and personal consequences for collegiate and professional sportsThe COVID-19 pandemic is having major economic and personal consequences for collegiate and professional sports. It is proposed that vitamin D supplementation be included as a method by which to reduce the risk of SARS-CoV-2 infection and progression to and severity of COVID-19. Evidence supporting this suggestion includes approximately 30 observational studies from several countries finding that serum 25-hydroxyvitamin D [25(OH)D] concentrations are inversely correlated with SARS-CoV-2 infection and severity, progression and risk of death of COVID-19. In addition, “quasi-experimental” studies in France found that COVID-19 patients receiving high-dose vitamin D supplements before or shortly after development of COVID-19 had significantly reduced risk of death. A pilot randomized controlled trial in Spain using high-dose 25(OH)D3 on COVID-19 patients found significant reductions in progression to the intensive care unit and death. Sports teams are already aware of the better athletic performance associated with higher 25(OH)D concentrations and vitamin D supplementation. Thus, supplementing with vitamin D by athletes and associated staff could add an extra measure of protection against COVID-19 as well as help maintain peak athletic ability. This review provides guidelines for supplementation.  
  • 612
  • 16 Jun 2021
Topic Review
Atopic Dermatitis (AD)
The skin harbors a huge number of different microorganisms such as bacteria, fungi and viruses, and it acts as a protective shield to prevent the invasion of pathogens and to maintain the health of the commensal microbiota. Several studies, in fact, have shown the importance of the skin microbiota for healthy skin. This balance can be altered by intrinsic and extrinsic factors, leading to the development of skin disease, such as acne vulgaris (AV), atopic dermatitis (AD) and rosacea (RS).
  • 717
  • 27 Oct 2022
Topic Review
Atopic Dermatitis and Food Allergy
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by intense pruritus, eczematous lesions, and relapsing course. It presents with great clinical heterogeneity, while underlying pathogenetic mechanisms involve a complex interplay between a dysfunctional skin barrier, immune dysregulation, microbiome dysbiosis, genetic and environmental factors. All these interactions are shaping the landscape of AD endotypes and phenotypes. In the “era of allergy epidemic”, the role of food allergy (FA) in the prevention and management of AD is a recently explored area.
  • 519
  • 05 Aug 2022
Topic Review
Atopic Dermatitis and Water
Water is a vital nutrient with innumerable functions for every living cell. The functions of human skin include protection against dehydration of the body. Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease that presents with dry skin, erythematous and eczematous lesions, and lichenification. 
  • 323
  • 08 Feb 2023
Topic Review
Atopic Dermatitis in Latin America
Atopic dermatitis (AD) is a prevalent condition in Latin America that can have a substantial impact on quality of life. Diagnosing AD is challenging due to broad clinical features and lack of universal diagnostic criteria. Furthermore, lack of physician training, barriers to access, and socioeconomic inequalities hinder effective disease management. Ethnoracial disparities in AD need to be addressed, as they may impact not only in the diagnosis, but also in severity scores which are relevant parameters for evaluating the efficacy of therapeutic agents. 
  • 336
  • 18 May 2023
Topic Review
Atopic Dermatitis—Beyond the Skin
Atopic dermatitis is a chronic inflammatory disease that can arise during the first months of life or at maturity and have a significant negative impact on the quality of life. The main pathogenic mechanism is the breakdown of cutaneous barrier integrity, which is associated with systemic inflammatory immunologic disorders. Atopic dermatitis involves numerous immunologic, allergic, respiratory, and ophthalmologic comorbidities that develop through similar intricate pathogenic phenomena.
  • 614
  • 30 Sep 2021
Topic Review
Atopic March or Atopic Multimorbidity
The atopic march encompasses a sequence of allergic conditions, including atopic dermatitis, food allergy, allergic rhinitis, and asthma, that frequently develop in a sequential pattern within the same individual. It was introduced as a conceptual framework aimed at elucidating the developmental trajectory of allergic conditions during childhood. Following the introduction of this concept, it was initially believed that the atopic march represented the sole and definitive trajectory of the development of allergic diseases. 
  • 287
  • 03 Jan 2024
Topic Review
Atorvastatin
Atorvastatin (ATS) is the gold-standard treatment worldwide for the management of hypercholesterolemia and prevention of cardiovascular diseases associated with dyslipidemia.
  • 937
  • 01 Jun 2021
  • Page
  • of
  • 1352
ScholarVision Creations